Impacts of COVID-19 in Pathology and
Cancer Care.
Dr. Kaitlin Sundling, MD, PhD
discusses the impact of COVID-19 on cancer patients and needed
precautions the healthcare system needs to adopt to augment the safety
of immunocompromised patients. A comprehensive listing of topics and
discussions are listed in the timeline below.
Health Watch USAsm meeting: April. 17, 2024.
https://youtu.be/K22GqxLKrRg
Timeline
02:00 Pap test a public health success story.
04:31 Decrease in cancer screening during the pandemic.
05:54 Recommended time for initial HPV primary screening.
07:46 Impact of COVID-19 on cancer screening.
09:18 Parallels between COVID-19 antivax movement and HPV vaccination
adoption.
12:06 Other Viruses which can cause cancer (HPB, HBV, EBV, HIV, HHV-8,
HTLV-1, Merkel cell Polyomavirus).
13:14 COVID-19's lung damage pathology.
15:02 Pathology examples of COVID-19's multi-system organ damage.
15:39 Long-term impact of COVID-19 on cancer risks is not known.
16:53 Many forms of Long COVID.
17:38 How can cancer patients decrease the chances of catching COVID-19?
19:27 Healthcare facilities and providers need to implement strategies
to protect high-risk patients.
20:24 COVID-19 vaccination of cancer patients.
21:07 Cancer increases the risk of COVID-19.
22:15 Expert disagreement with the CDC's relaxation of COVID-19
preventive strategies.
23:11 Misinformation similarities with COVID-19 and cancer.
24:21 Impact of COVID-19 on pathology practices and resident training,
along with mitigation strategies.
26:51 Need for multi-layered COVID protections and virtual options in
medical training and conferences.
28:06 Impact of artificial intelligence on pathological practices.
30:37 Dr. Rudolf Virchow: An old but new approach to medicine.
31:38 References and Resources
An expanded version of this talk (41 minutes) with a more detailed
description of the PAP Test and HPV diagnoses along with an expanded
comparison of automated versus human microscopic pathological diagnosis
can be viewed at:
https://youtu.be/76RIdKi34U8
|